Download PDFPDF
CP-179 Effects of reimbursement changes on use of erytropoiesis stimulating agents in dialysis patients
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address